Literature DB >> 18176365

Incidence of inflammatory bowel disease in Corsica from 2002 to 2003.

Abakar Abakar-Mahamat1, Jérôme Filippi, Christian Pradier, Adrien Dozol, Xavier Hébuterne.   

Abstract

OBJECTIVES: The aim of this prospective epidemiological study was to determine the incidence of inflammatory bowel diseases (IBD) in Corsica using the same methodology as that of the EPIMAD registry.
METHODS: Between January 1st, 2002 and December 31, 2003, all gastroenterologists in Corsica (N=19) enrolled patients consulting for the first time with clinical symptoms compatible with IBD. Each case was reviewed by another expert gastroenterologist to assign a diagnosis of definite, probable, possible Crohn's disease (CD), ulcerative colitis (UC) or unclassified/able chronic colitis. RESULT: Eighty-one new cases were recorded, including seventy-one diagnoses of IBD (definite and probable cases), with 20 (28%) CD, 49 (69%) UC and 2 (3%) unclassifiable chronic colitis. The age-adjusted incidence (per 105 inhabitants/year) was 4.05 for CD and 9.5 for UC. The female/male ratio and median age at time of diagnosis were 1.3 and 29 years for CD and 0.63 and 44 years for UC, respectively. The median time from symptom onset to diagnosis was five months for both diseases.
CONCLUSION: In Corsica, the observed incidence of CD is close to that observed in other metropolitan French regions. These data are contrary to the north-south gradient reported for this disease. Our figure of 9.5/10(5) for UC in Corsica is two-fold higher than reported in other metropolitan French regions. Genetic and/or environmental factors may explain these findings.

Entities:  

Mesh:

Year:  2007        PMID: 18176365     DOI: 10.1016/s0399-8320(07)78343-4

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  7 in total

Review 1.  Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing?

Authors:  Cristina Saro Gismera; Beatriz Sicilia Aladrén
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

Review 2.  Linking vitamin d deficiency to inflammatory bowel disease.

Authors:  Matthew T Palmer; Casey T Weaver
Journal:  Inflamm Bowel Dis       Date:  2013-09       Impact factor: 5.325

3.  The impact of biologics on health-related quality of life in patients with inflammatory bowel disease.

Authors:  Lauran Vogelaar; Adriaan Van't Spijker; C Janneke van der Woude
Journal:  Clin Exp Gastroenterol       Date:  2009-09-25

4.  Environmental variables and genome-environment interactions predicting IBD diagnosis in large UK cohort.

Authors:  Alan Z Yang; Luke Jostins-Dean
Journal:  Sci Rep       Date:  2022-06-28       Impact factor: 4.996

5.  p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways.

Authors:  Maria Shatz; Igor Shats; Daniel Menendez; Michael A Resnick
Journal:  Oncotarget       Date:  2015-07-10

Review 6.  Current global trends in the incidence of pediatric-onset inflammatory bowel disease.

Authors:  Josef Sýkora; Renáta Pomahačová; Marcela Kreslová; Dominika Cvalínová; Přemysl Štych; Jan Schwarz
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

7.  Global smoking trends in inflammatory bowel disease: A systematic review of inception cohorts.

Authors:  Tom Thomas; Joht Singh Chandan; Venice Sze Wai Li; Cheuk Yin Lai; Whitney Tang; Neeraj Bhala; Gilaad G Kaplan; Siew C Ng; Subrata Ghosh
Journal:  PLoS One       Date:  2019-09-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.